Hepatitis C Therapy - euro adhoc: Intercell AG / other / Intercell's Hepatitis C vaccine meets success criteria for further development -

euro adhoc: Intercell AG / other / Intercell's Hepatitis C vaccine meets success criteria for further development -
Presseportal - Jan 31 9:08 AM
31.01.2006 Intercell (VSE; "ICLL") today announced initial data from a clinical trial aiming at the optimization of its therapeutic Hepatitis C vaccine IC41. Results ...Save to My Web

Schering-Plough Reports FDA Grants Fast Track Designation to Oral HCV Protease Inhibitor SCH 503034
[Press Release] PR Newswire via Yahoo! Finance - Jan 30 6:18 AM
Schering-Plough today reported that the U.S. Food and Drug Administration has granted Fast Track designation to its investigational oral hepatitis C protease inhibitor , currently in Phase II clinical development for the treatment of chronic hepatitis C virus infection.Save to My Web

Vertex drug shows promise in hepatitis C
Pharmaceutical Business Review - Jan 10 5:54 PM
New data from a phase Ib study show that Vertex Pharmaceuticals VX-950 dosed in combination with pegylated interferon alfa-2a, achieved a rapid and dramatic reduction in virus levels in genotype 1 patients with chronic hepatitis C infection.Save to My Web

Inovio and Tripep to Develop Hepatitis C Vaccine
RedNova - Jan 17 7:30 PM
Inovio Biomedical has signed an agreement with Swedish-based Tripep to develop a therapeutic vaccine for hepatitis C virus.Save to My Web

Peregrine Accelerates Tarvacin HCV Study
AP via Yahoo! Finance - Jan 18 5:28 AM
Biopharmaceutical company Peregrine Pharmaceuticals Inc. said Wednesday that it is accelerating its program to test its cancer drug Tarvacin for the treatment of hepatitis C.Save to My Web